Evaluation of the effect of high flow oxygen delivery under different temperatures in COVID-19 patients

Phase 2

Recruiting

• Conditions: U07.01; COVID-19.; COVID-19

• Registration Number: IRCT20200611047727N4
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

New coronavirus detection (clinical or paraclinical)
Oxygen saturation less than 90%
Written consent to participate in the study
Age over 18 years
Moderate to severe Covid-19 disease is hospitalized and requires respiratory support

Exclusion Criteria

PaCO2>65
PH<7.28
Cardiovascular disorders that prevent pulmonary rehabilitation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ferritin. Timepoint: Before starting oxygen therapy, 24 hours later, 7 days later. Method of measurement: Laboratory tests.;Oxygen saturation. Timepoint: Before starting oxygen therapy, 24 hours later. Method of measurement: Pulse oxymetry.;Partial pressure of carbon dioxide. Timepoint: Before starting oxygen therapy, 24 hours later, 7 days later. Method of measurement: VBG analysis.;Interleukin 6. Timepoint: Before starting oxygen therapy, 24 hours later, 7 days later. Method of measurement: Laboratory tests.;C-Reactive Protein. Timepoint: Before starting oxygen therapy, 24 hours later, 7 days later. Method of measurement: Laboratory tests.;Erythrocyte Sedimentation Rate. Timepoint: Before starting oxygen therapy, 24 hours later, 7 days later. Method of measurement: Laboratory tests.

Secondary Outcome Measures

Name	Time	Method
Borg scale. Timepoint: Before starting oxygen therapy, every day for a week. Method of measurement: Borg questionnaire.